| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |